Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
ESSA Pharma
(NASDAQ:EPIX)
Intraday
$5.6876
-0.0124
[-0.22%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$5.6876
-0.0124
[-0.22%]
Last update: 12:18PM
Get Real Time Here
Get Report
Watch
Q2 2024 Earnings were released on Tue May 14th, before the market open
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for ESSA Pharma Stock (NASDAQ:EPIX)
ESSA Pharma Stock (NASDAQ: EPIX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, May 16, 2024
Oppenheimer Maintains Outperform on ESSA Pharma, Maintains $17 Price Target
Benzinga Newsdesk
-
4 days ago
Tuesday, February 13, 2024
ESSA Pharma: Q1 Earnings Insights
Benzinga Insights
-
Feb 13, 2024, 9:10AM
Tuesday, January 30, 2024
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
Benzinga Insights
-
Jan 30, 2024, 12:06PM
Friday, January 26, 2024
Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Jan 26, 2024, 10:30AM
What's Going On With Prostate Cancer Focused ESSA Pharma Stock Today?
Vandana Singh
-
Jan 26, 2024, 8:51AM
Thursday, January 25, 2024
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Jan 25, 2024, 2:52PM
ESSA Pharma Presents Updated Phase 1 Masofaniten Clinical Data At The 2024 ASCO Genitourinary Cancers Symposium
Benzinga Newsdesk
-
Jan 25, 2024, 10:01AM
Tuesday, January 16, 2024
Applied Digital, ESSA Pharma And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
Avi Kapoor
-
Jan 16, 2024, 5:53AM
Wednesday, December 13, 2023
Oppenheimer Reiterates Outperform on ESSA Pharma, Maintains $17 Price Target
Benzinga Newsdesk
-
Dec 13, 2023, 11:36AM
Tuesday, December 12, 2023
ESSA Pharma Q4 EPS $(0.12) Up From $(0.14) YoY with Cash Balance of $148.1M and a Runway Likely to Fund its Planned Operations Through 2025
Benzinga Newsdesk
-
Dec 12, 2023, 7:05AM
Recap: ESSA Pharma Q4 Earnings
Benzinga Insights
-
Dec 12, 2023, 7:05AM
Monday, November 06, 2023
Essa Pharma Announced It May Offer And Sell Common Shares Having An Aggregate Offering Price Of Up To $50M From Time To Time Through Jefferies
Charles Gross
-
Nov 6, 2023, 6:10AM
Saturday, October 21, 2023
ESSA Pharma Announced Data Combination Of Masofaniten Plus Enzalutamide Continues To Be Well Tolerated With Deep And Durable Reductions In PSA In Patients With Metastatic Castration-Resistant Prostate Cancer
Charles Gross
-
Oct 21, 2023, 9:17AM
Monday, October 16, 2023
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Oct 16, 2023, 1:09PM
Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 16, 2023, 8:47AM
Monday, September 18, 2023
ESSA Pharma Announces Initiation Of Phase 2 Study Evaluating Masofaniten (EPI-7386) In Combination with Enzalutamide In Patients with Metastatic Castration-Resistant Prostate Cancer
Benzinga Newsdesk
-
Sep 18, 2023, 7:02AM
Monday, August 14, 2023
Watching ESSA Pharma; Zacks Small-Cap Research Sets $27 Price Valuation; Phase 2 Trial Of EPI-7386 in Combination With Enzalutamide To Initiate In Calendar 3Q23
Happy Mohamed
-
Aug 14, 2023, 12:12PM
Wednesday, August 09, 2023
Oppenheimer Reiterates Outperform on ESSA Pharma, Maintains $17 Price Target
Benzinga Newsdesk
-
Aug 9, 2023, 9:50AM
Monday, June 26, 2023
Oppenheimer Assumes ESSA Pharma at Outperform, Announces Price Target of $17
Benzinga Newsdesk
-
Jun 26, 2023, 6:48AM
Thursday, May 18, 2023
Watching ESSA Pharma; Zacks Small-Cap Research Sets $27 Price Valuation; Says This Model Is Highly Dependent Upon Continued Clinical Success Of EPI-7386/TPD And Will Be Adjusted Accordingly Based Upon Future Clinical Results
Happy Mohamed
-
May 18, 2023, 10:04AM
Tuesday, May 09, 2023
ESSA Pharma: Q2 Earnings Insights
Benzinga Insights
-
May 9, 2023, 10:05AM
Wednesday, April 12, 2023
Essa Pharma Has Entered Into A Clinical Trial Support Agreement With Janssen Research & Development To Evaluate Its EPI-7386, Combined With Apalutamide As Well As The Combination Of EPI-7386 With Abiraterone Acetate Plus Prednisone For Prostate Cancer
Benzinga Newsdesk
-
Apr 12, 2023, 7:06AM
Monday, February 13, 2023
ESSA Pharma Announces Presentation At ASCO On Feb 16-19
Benzinga Newsdesk
-
Feb 13, 2023, 5:03PM
Monday, December 19, 2022
Watching ESSA Pharma; Zacks Small-Cap Research Sets $27 Price Valuation
Benzinga Newsdesk
-
Dec 19, 2022, 11:03AM
Tuesday, December 13, 2022
ESSA Pharma Q4 EPS $(0.14) Up From $(0.20) YoY
Bill Haddad
-
Dec 13, 2022, 7:05AM
Monday, November 14, 2022
Watching ESSA Pharma; Zack's Small-Cap Research Sets $25 Valuation
Benzinga Newsdesk
-
Nov 14, 2022, 2:07PM
Friday, November 11, 2022
Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock
Blue Star Foods
-
Nov 11, 2022, 8:41AM
Tuesday, November 01, 2022
Ten Stocks Trending on Discord for Tuesday November 1, 2022: SOFI, SONN, AMZN, UBER, META, EPIX, NIO, UBX, VRNS, SFET
Charles Gross
-
Nov 1, 2022, 1:29PM
'Essa Pharma Has Been Granted U.S. Patent Number 11,485,713 Titled "Androgen Receptor Modulators And Methods For Their Use (For Treatment Of Disorders Including Prostate Cancer)"'
Benzinga Newsdesk
-
Nov 1, 2022, 12:02PM
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Lisa Levin
-
Nov 1, 2022, 3:31AM
Monday, October 31, 2022
Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Oct 31, 2022, 12:21PM
Ten Stocks Trending on Discord for Monday October 31, 2022: GME, SONN, DBGI, AAPL, AMC, ATNM, META, HOTH, EPIX, BBBY
Charles Gross
-
Oct 31, 2022, 11:24AM
ESSA Pharma Shares Tank As Janssen Stops Enrollment In EPI-7386 Combo Prostate Cancer Trials
Vandana Singh
-
Oct 31, 2022, 11:13AM
$8.2 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Lisa Levin
-
Oct 31, 2022, 10:15AM
ESSA Pharma Shares Resume Trade Following Circuit Breaker Halt, Stock Now Down 18%
Benzinga Newsdesk
-
Oct 31, 2022, 9:37AM
ESSA Pharma Shares Halted On Circuit Breaker To The Upside, Stock Now Down 19.99%
Benzinga Newsdesk
-
Oct 31, 2022, 9:33AM
ESSA Pharma shares are trading lower after the company announced Janssen Research and Development is suspending enrollment into the Phase 1 clinical study of EPI-7386 with apalutamide or EPI-7386 with abiraterone acetate plus prednisone.
Benzinga Newsdesk
-
Oct 31, 2022, 9:32AM
ESSA Collaborator Janssen Suspends Enrollment In Phase 1 Study Of EPI-7386 With Apalutamide Or Abiraterone Acetate Plus Prednisone
Benzinga Newsdesk
-
Oct 31, 2022, 7:06AM
Friday, October 28, 2022
Ten Stocks Trending on Discord for Friday October 28, 2022: AMZN, AAPL, TWTR, TSLA, INTC, XOM, NUVL, AGLE, ZVO, EPIX
Charles Gross
-
Oct 28, 2022, 10:30AM
Thursday, October 27, 2022
Ten Stocks Trending on Discord for Thursday October 27, 2022: AMZN, AAPL, META, EPIX, AGFS, INTC, VIEW, SHOP, UAVS, MSFT
Charles Gross
-
Oct 27, 2022, 5:52PM
ESSA Pharma Shares Resume Trade Following Circuit Breaker Halt, Stock Now Down 2.7%
Benzinga Newsdesk
-
Oct 27, 2022, 11:17AM
ESSA Pharma Shares Halted On Circuit Breaker To The Upside, Stock Now Down 7.68%
Benzinga Newsdesk
-
Oct 27, 2022, 11:12AM
As Of October 26 13G Filing Shows Avidity Partners Management LP Reports 8.5% Passive Stake In Essa Pharma Inc
Benzinga Newsdesk
-
Oct 27, 2022, 10:02AM
Why Meta Platforms Shares Are Trading Sharply Lower; Here Are 25 Stocks Moving Premarket
Lisa Levin
-
Oct 27, 2022, 7:06AM
Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday
Lisa Levin
-
Oct 27, 2022, 2:39AM
Wednesday, October 26, 2022
Nasdaq Drops Over 200 Points; Microsoft Shares Down After Q1 Results
Lisa Levin
-
Oct 26, 2022, 2:58PM
Ten Stocks Trending on Discord for Wednesday October 26, 2022: EPIX, MSFT, SINT, BBBY, ENSC, GOVX, GOOGL, GOOG, META, RNAZ
Charles Gross
-
Oct 26, 2022, 2:03PM
Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Oct 26, 2022, 12:35PM
ESSA Pharma Shares Resume Trade
Benzinga Newsdesk
-
Oct 26, 2022, 12:07PM
ESSA Pharma Shares Halted On Circuit Breaker
Benzinga Newsdesk
-
Oct 26, 2022, 12:01PM
Show more